Overview

Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetic After Oral Administration of CKD-341 and D958 in Healthy Adults

Status:
COMPLETED
Trial end date:
2023-09-15
Target enrollment:
Participant gender:
Summary
A clinical trial to compare and evaluate the safety and pharmacokinetics of CKD-341
Phase:
PHASE1
Details
Lead Sponsor:
Chong Kun Dang Pharmaceutical